![Core Concepts - Extrahepatic Conditions Related to HCV infection - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online Core Concepts - Extrahepatic Conditions Related to HCV infection - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online](https://cdn.hepatitisc.uw.edu/doc/483-1/major-pathophysiological-mechanisms-implicated-extrahepatic-manifestations-hcv-infection.jpg)
Core Concepts - Extrahepatic Conditions Related to HCV infection - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online
![IJMS | Free Full-Text | Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed IJMS | Free Full-Text | Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed](https://www.mdpi.com/ijms/ijms-18-00962/article_deploy/html/images/ijms-18-00962-g001a.png)
IJMS | Free Full-Text | Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed
![Interferon and ribavirin for chronic hepatitis C: should it be administered in the new treatment era? Interferon and ribavirin for chronic hepatitis C: should it be administered in the new treatment era?](https://actagastro.org/wp-content/uploads/2017/04/MO-15-051-IMG03.jpeg)
Interferon and ribavirin for chronic hepatitis C: should it be administered in the new treatment era?
![Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C - The Lancet Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C - The Lancet](https://www.thelancet.com/cms/attachment/2001928114/2006662509/gr1.gif)
Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C - The Lancet
![SciELO - Brasil - Treatment of chronic hepatitis C in treatment-naïve patients Treatment of chronic hepatitis C in treatment-naïve patients SciELO - Brasil - Treatment of chronic hepatitis C in treatment-naïve patients Treatment of chronic hepatitis C in treatment-naïve patients](https://minio.scielo.br/documentstore/1678-4391/QYd4dfhPQqHxbJYjws7sMqw/85308efb6d05af4c3a3c2b5488d91d5a506d6b06.gif)
SciELO - Brasil - Treatment of chronic hepatitis C in treatment-naïve patients Treatment of chronic hepatitis C in treatment-naïve patients
![Cureus | Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection | Article Cureus | Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection | Article](https://assets.cureus.com/uploads/figure/file/236735/lightbox_86a98550df4b11ebafa4d34d891be251-Screen-Shot-2021-07-02-at-12.12.59-AM.png)
Cureus | Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection | Article
![Contraindications for and common side effects of inter- feron alfa and... | Download Scientific Diagram Contraindications for and common side effects of inter- feron alfa and... | Download Scientific Diagram](https://www.researchgate.net/publication/11445125/figure/tbl1/AS:770707394932741@1560762370802/Contraindications-for-and-common-side-effects-of-inter-feron-alfa-and-ribavirin-therapy.png)
Contraindications for and common side effects of inter- feron alfa and... | Download Scientific Diagram
![Short versus standard treatment with Pegylated interferon alfa-2a plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the CLEO trial. – topic of research paper in Clinical medicine. Download Short versus standard treatment with Pegylated interferon alfa-2a plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the CLEO trial. – topic of research paper in Clinical medicine. Download](https://cyberleninka.org/viewer_images/415062/f/1.png)
Short versus standard treatment with Pegylated interferon alfa-2a plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the CLEO trial. – topic of research paper in Clinical medicine. Download
Full article: Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
![Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C | NEJM Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1998/nejm_1998.339.issue-21/nejm199811193392102/production/images/img_medium/nejm199811193392102_t1.jpeg)
Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C | NEJM
![PDF] Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. | Semantic Scholar PDF] Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9ced2b2becd29b4342952a49f534b2f9f0e08131/3-Figure1-1.png)